Zobrazeno 1 - 6
of 6
pro vyhledávání: '"William Crago"'
Autor:
Jason Ho, Chelsie Macedo, Garrett Cyprus, Rajay Pandit, Anya Polovina, Nadja Kern, Abrahim Hussain, Sae Jeong Ahn, William Crago, Emily Rowell, Florian J Sulzmaier, John C Timmer, Brendan P Eckelman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background As a major driver of lymphocyte proliferation and activation interleukin 2 (IL-2) is a crucial mediator for antitumor responses. Despite promising activity in a subset of patients, wider therapeutic utility of IL-2 (aldesleukin) has been h
Externí odkaz:
https://doaj.org/article/1128664e4a4f45238e95ab92d708e9bf
Autor:
Heather Kinkead, Chelsie Macedo, Angelica Sanabria, Rajay Pandit, Florian Sulzmaier, John Timmer, Brendan Eckelman, Analeah Heidt, Anya Polovina, Nadja Kern, Abrahim Hussain, Sae Jeong Ahn, William Crago
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c3600c19b90545af82b567ddd7c57bd7
Autor:
Quinn Deveraux, Heather Kinkead, Kyle Jones, Bryan Becklund, Florian Sulzmaier, John Timmer, Brendan Eckelman, Analeah Heidt, William Crago, Emily Rowell, Elisabeth Torretti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c90df63d30a64fb7913fc0ac2ef23f54
Autor:
Florian J Sulzmaier, Nadja Kern, Sae Jeong Ahn, Anya Polovina, Jason Ho, Abrahim Hussain, Garrett Cyprus, Chelsie Macedo, Rajay Pandit, William Crago, Emily Rowell, John C Timmer, Brendan P Eckelman
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006116
BackgroundAs a major driver of lymphocyte proliferation and activation interleukin 2 (IL-2) is a crucial mediator for antitumor responses. Despite promising activity in a subset of patients, wider therapeutic utility of IL-2 (aldesleukin) has been ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb63a7d2dee966e640f9980c428d7b5
https://doi.org/10.1136/jitc-2022-006116
https://doi.org/10.1136/jitc-2022-006116
Autor:
Heather Kinkead, Florian J. Sulzmaier, Anya Polovina, Nadja Kern, Angelica Sanabria, Jason Ho, Chelsie Macedo, Ryan Henderson, Abrahim Hussain, Rajay Pandit, William Crago, Emily Rowell, Brendan P. Eckelman
Publikováno v:
Cancer Research. 82:3513-3513
IL-2 is a powerful cytokine that enhances the activity of and induces the expansion of tumoricidal effector cells including T and NK cells. Despite promising signs of activity, the clinical utility of IL-2 is limited due to severe treatment-associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc43523f8c9f6e6ffb54f9ffec3bfc9d
https://doi.org/10.1158/1538-7445.am2022-3513
https://doi.org/10.1158/1538-7445.am2022-3513
Autor:
William Crago
Publikováno v:
The English Journal. 76:57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::401a9c729ab6b0c7fdc977e34d266a53
https://doi.org/10.2307/818170
https://doi.org/10.2307/818170